IL327478A - D מעכבי dclk1 ושיטות לטיפול - Google Patents
D מעכבי dclk1 ושיטות לטיפולInfo
- Publication number
- IL327478A IL327478A IL327478A IL32747826A IL327478A IL 327478 A IL327478 A IL 327478A IL 327478 A IL327478 A IL 327478A IL 32747826 A IL32747826 A IL 32747826A IL 327478 A IL327478 A IL 327478A
- Authority
- IL
- Israel
- Prior art keywords
- cancer
- dclk1
- inhibitor compound
- pct
- oil
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202363587362P | 2023-10-02 | 2023-10-02 | |
| PCT/US2024/049605 WO2025076093A1 (en) | 2023-10-02 | 2024-10-02 | Dclk1 inhibitors and methods of treatment |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL327478A true IL327478A (he) | 2026-05-01 |
Family
ID=95284159
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL327478A IL327478A (he) | 2023-10-02 | 2024-10-02 | D מעכבי dclk1 ושיטות לטיפול |
Country Status (5)
| Country | Link |
|---|---|
| EP (1) | EP4788329A1 (he) |
| CN (1) | CN122161595A (he) |
| AU (1) | AU2024355086A1 (he) |
| IL (1) | IL327478A (he) |
| WO (1) | WO2025076093A1 (he) |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2017518312A (ja) * | 2014-06-05 | 2017-07-06 | ユニバーシティ・オブ・カンザス | マルメリン類似体および癌治療における使用方法 |
-
2024
- 2024-10-02 EP EP24875307.1A patent/EP4788329A1/en active Pending
- 2024-10-02 AU AU2024355086A patent/AU2024355086A1/en active Pending
- 2024-10-02 CN CN202480065900.6A patent/CN122161595A/zh active Pending
- 2024-10-02 WO PCT/US2024/049605 patent/WO2025076093A1/en not_active Ceased
- 2024-10-02 IL IL327478A patent/IL327478A/he unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP4788329A1 (en) | 2026-08-12 |
| CN122161595A (zh) | 2026-06-05 |
| AU2024355086A1 (en) | 2026-05-14 |
| WO2025076093A1 (en) | 2025-04-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL320388A (he) | מעכבי kras מקרוציקליים ושיטות שימוש | |
| IL297625B2 (he) | מעכבי pi3k-אלפא ושיטות לשימוש בהם | |
| IL321357A (he) | מעכבי kif18a ושימושים שלהם | |
| IL318169A (he) | מעכבי Apol1 ושיטות שימוש זהות | |
| IL319748A (he) | מעכבי pcsk9 ושיטות לשימוש בהם | |
| IL316619A (he) | מעכבי pi3kα ושיטות לשימוש בהם | |
| IL312348A (he) | מעכבי hif-2alpha ושיטות השימוש בו | |
| IL310812A (he) | צורות מוצקות של מעכבי apol1 spirotricyclic ושיטות שימושן | |
| IL314320A (he) | תרכובות ושיטות לשימוש | |
| IL320848A (he) | מעכבי ripk2 ושימושים רפואיים בהם | |
| IL315503A (he) | שיטות לטיפול | |
| IL318393A (he) | תרכובות אזא-קווינאזולין ושיטות לשימוש | |
| IL320711A (he) | שיטות טיפול | |
| IL317288A (he) | מעכבי ביטוי ו/או תפקוד | |
| IL314277A (he) | תרכובות אנטי- b7-h3 ושיטות לשימוש | |
| GB202201824D0 (en) | Methods of treatment | |
| IL327384A (he) | מעכבי cbl-b ושיטות לשימוש בהם | |
| AU2024355086A1 (en) | Dclk1 inhibitors and methods of treatment | |
| GB202317431D0 (en) | Arrangement and method for treatment of fish | |
| GB2607584B (en) | Composition and method of treatment | |
| GB202201819D0 (en) | Methods of treatment | |
| GB202201825D0 (en) | Methods of treatment | |
| EP4117622B1 (en) | NEW USE AND NEW PROCESSING METHOD | |
| IL317043A (he) | מעכבים של ripk1 ושיטות לשימוש | |
| AU2021902069A0 (en) | Methods of treatment and inhibition |